Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Daniel J. Touw"'
Autor:
Sheseira T. L. Struiken, Danique Lobée, Eline L. van Tuinen, Daniel J. Touw, Hester van der Vaart, Arno R. Bourgonje, Bart L. Rottier, Gerard H. Koppelman, Paola Mian
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 9, p 2641 (2024)
Introduction: Patients with cystic fibrosis (CF) commonly experience pulmonary exacerbations, and it is recommended by the TOPIC study to treat this with tobramycin at a dose of 10 mg/kg once daily. The aim of this study was to evaluate the target at
Externí odkaz:
https://doaj.org/article/1bd170a101f246a7a464ee48f1c4dcbd
Autor:
Anne M. Akkerman-Nijland, Bart L. Rottier, Joanne Holstein, Rik L.J. Winter, Daniel J. Touw, Onno W. Akkerman, Gerard H. Koppelman
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/b15a6c801768479ba6a3fdfb4dd2d323
Autor:
Anne M. Akkerman-Nijland, Bart L. Rottier, Joanne Holstein, Rik L.J. Winter, Daniel J. Touw, Onno W. Akkerman, Gerard H. Koppelman
Publikováno v:
ERJ Open Research. :00055-2023
This case series suggests that successful eradication therapy of BCC in cystic fibrosis can be done with a combination of inhaled and oral medication, which in many cases may eliminate the need for intensive treatment with intravenous antibiotics htt
Autor:
Gerard H. Koppelman, Floris Grasmeijer, Bart L. Rottier, A M Akkerman-Nijland, Onno W. Akkerman, Henderik W. Frijlink, Paul Hagedoorn, Daniel J. Touw
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 17:53-68
Introduction Dosing of antibiotics in people with cystic fibrosis (CF) is challenging, due to altered pharmacokinetics, difficulty of lung tissue penetration, and increasing presence of antimicrobial resistance. Areas covered The purpose of this work
Autor:
Daniel J. Touw, Stefan P Berger, Anna van der Voort, Stephanus Johannes Leonardus Bakker, Herman Veenhof, Job Frank Martien van Boven
Publikováno v:
British Journal of Clinical Pharmacology
Aims Dried blood spot (DBS) home sampling allows monitoring creatinine levels and tacrolimus trough levels as an alternative for blood sampling in the hospital, which is important in kidney transplant patient follow-up. This study aims to assess whet
Autor:
Ingrid J. Bosman, Dick-Paul Kloos, Anne Elisa Maria Kamphuis, Daniel J. Touw, Rogier van der Hulst, Lennaert Christiaan Pieter Borra, Dingeman Johannes Rijken
Publikováno v:
Forensic Science International, 329:111094
INTRODUCTION: In the field of forensic toxicology, many unexpected deaths are investigated as to whether toxicological substances may have caused or contributed to someone's death. One of the factors that makes interpretation of the results of quanti
Autor:
Lisanne M Geers, Bob Wilffert, Taichi Ochi, Daniel J. Touw, Innokentiy S. Losenkov, G. G. Simutkin, Nikolay A. Bokhan, Diana Z Paderina, Svetlana A. Ivanova, Natalya M. Vyalova, Anton J. M. Loonen, Ivan V Pozhidaev
Publikováno v:
Human Psychopharmacology, 37(3):e2826. John Wiley and Sons Ltd
Human psychopharmacology: clinical and experimental. 2022. Vol. 37, № 3. P. e2826 (1-10)
Human psychopharmacology: clinical and experimental. 2022. Vol. 37, № 3. P. e2826 (1-10)
Background Many antidepressants are substrates of P-glycoprotein, an efflux transporter in the blood-brain-barrier encoded by the ABCB1 gene. Genetic variations might influence the transport rate of antidepressants and hence their pharmacological eff
Autor:
Nicolas Simon, Pieter Colin, Dolores Santos-Buelga, Karel Allegaert, Michael J. Dolton, Michel Struys, Alison H. Thomson, Daniel J. Touw, Jason A. Roberts, Fabio Silvio Taccone, Ana Martín-Suárez, Matthijs de Hoog, Emilia Barcia, Masato Yamamoto, Lo Yl, Douglas J. Eleveld, Eyob Adane
Publikováno v:
Clinical Pharmacokinetics, 58(6), 767-780. Adis
Clinical Pharmacokinetics, 58(6), 767-780. Springer International Publishing AG
Clinical Pharmacokinetics
Clinical Pharmacokinetics, Springer Verlag, 2019, 58 (6), pp.767-780. ⟨10.1007/s40262-018-0727-5⟩
Clinical pharmacokinetics, 58 (6
CLINICAL PHARMACOKINETICS
Clinical Pharmacokinetics, 58(6), 767-780. Springer International Publishing AG
Clinical Pharmacokinetics
Clinical Pharmacokinetics, Springer Verlag, 2019, 58 (6), pp.767-780. ⟨10.1007/s40262-018-0727-5⟩
Clinical pharmacokinetics, 58 (6
CLINICAL PHARMACOKINETICS
Background and Objectives: Uncertainty exists regarding the optimal dosing regimen for vancomycin in different patient populations, leading to a plethora of subgroup-specific pharmacokinetic models and derived dosing regimens. We aimed to investigate
Publikováno v:
Therapeutic Drug Monitoring, 42(4), 595-599. LIPPINCOTT WILLIAMS & WILKINS
Background In the era of multiple daily dosing of systemic aminoglycosides, a circadian rhythm in the clearance of these vital antibiotics has been demonstrated in animals and healthy volunteers. Over the past decade, once-daily dosing regimens have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe8ae9eacf6f6f66bad87523c8d88de
https://cris.maastrichtuniversity.nl/en/publications/2b03458a-4901-4682-9a7a-46f7eebf982e
https://cris.maastrichtuniversity.nl/en/publications/2b03458a-4901-4682-9a7a-46f7eebf982e
Publikováno v:
Clinical Kidney Journal
Clinical kidney journal, 10(2), 282-290. Oxford University Press
Clinical Kidney Journal, 10(2), 282-290. Oxford Univ. Press, New York
Clinical kidney journal, 10(2), 282-290. Oxford University Press
Clinical Kidney Journal, 10(2), 282-290. Oxford Univ. Press, New York
Online haemodiafiltration (HDF) is increasingly used in clinical practice as a routine intermittent dialysis modality. It is well known that renal impairment and renal replacement therapy can substantially affect the pharmacokinetic behaviour of seve